Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2020 Filed Jun 1, 2020 20:46 UTC |
Joly HubertDirector
|
SaleCommon Stock | 147,400 | $78.27 | $11,536,776.90 |
DisclosureSEC source: 0001225208-20-008376 · doc4.xml · nonDerivative · entry 3 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,275.261 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.94, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:46 UTC |
Joly HubertDirector
|
SaleCommon Stock | 2,600 | $79.15 | $205,782.20 |
DisclosureSEC source: 0001225208-20-008376 · doc4.xml · nonDerivative · entry 2 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,675.261 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.01 to $79.38, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:46 UTC |
Joly HubertDirector
|
Exercise / conversionCommon Stock | 150,000 | $44.85 | $6,727,500.00 |
DisclosureSEC source: 0001225208-20-008376 · doc4.xml · nonDerivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614,275.261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,596 | $44.85 Strike: $44.85 | $1,147,980.60 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · derivative · entry 10 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 25,596 shares Expires 2027-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 92,825 | $40.85 Strike: $40.85 | $3,791,901.25 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · derivative · entry 9 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,825 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
SaleCommon Stock | 181,023 | $79.12 | $14,323,336.26 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 7 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,275.261 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.62 to $79.61, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
SaleCommon Stock | 21,868 | $80.23 | $1,754,423.72 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 6 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645,298.261 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.62 to $80.60, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
SaleCommon Stock | 17,925 | $80.86 | $1,449,497.96 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 5 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,166.261 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.633 to $81.34, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
Exercise / conversionCommon Stock | 25,596 | $44.85 | $1,147,980.60 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 4 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685,091.261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
Exercise / conversionCommon Stock | 92,825 | $40.85 | $3,791,901.25 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 3 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,495.261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:59 UTC |
Saksena AsheeshPresident, Best Buy Health
|
SaleCommon Stock | 12,000 | $80.84 | $970,134.00 |
DisclosureSEC source: 0001225208-20-008325 · doc4.xml · nonDerivative · entry 1 Saksena Asheesh · CIK 0001701497 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,920.583 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.83 to $80.849, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 65,620 | $40.85 Strike: $40.85 | $2,680,577.00 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · derivative · entry 8 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,825 Underlying: Common Stock · 65,620 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
SaleCommon Stock | 86,380 | $80.36 | $6,941,531.35 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 2 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,670.261 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.005 to $80.73, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:59 UTC |
Joly HubertDirector
|
Exercise / conversionCommon Stock | 65,620 | $40.85 | $2,680,577.00 |
DisclosureSEC source: 0001225208-20-008324 · doc4.xml · nonDerivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,050.261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Watson MathewSVP, Finance-Controller & CAO
|
SaleCommon Stock | 1,218 | $77.41 | $94,289.52 |
DisclosureSEC source: 0001225208-20-008228 · doc4.xml · nonDerivative · entry 1 Watson Mathew · CIK 0001639859 · SVP, Finance-Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,312 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Scarlett KathleenChief Human Resources Officer
|
SaleCommon Stock | 9,797 | $77.49 | $759,187.16 |
DisclosureSEC source: 0001225208-20-008227 · doc4.xml · nonDerivative · entry 1 Scarlett Kathleen · CIK 0001707469 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,908 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Saksena AsheeshPresident, Best Buy Health
|
SaleCommon Stock | 21,976 | $77.49 | $1,702,959.80 |
DisclosureSEC source: 0001225208-20-008226 · doc4.xml · nonDerivative · entry 1 Saksena Asheesh · CIK 0001701497 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,920.583 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Peterson AllisonChief Customer Officer
|
SaleCommon Stock | 1,090 | $77.41 | $84,380.61 |
DisclosureSEC source: 0001225208-20-008225 · doc4.xml · nonDerivative · entry 1 Peterson Allison · CIK 0001811659 · Chief Customer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,511 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
MOHAN RAJENDRA MPresident & COO
|
SaleCommon Stock | 28,263 | $77.49 | $2,190,150.74 |
DisclosureSEC source: 0001225208-20-008224 · doc4.xml · nonDerivative · entry 1 MOHAN RAJENDRA M · CIK 0001253507 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,413.293 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Joly HubertDirector
|
SaleCommon Stock | 101,274 | $77.49 | $7,847,904.55 |
DisclosureSEC source: 0001225208-20-008223 · doc4.xml · nonDerivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,430.261 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Hartman Todd G.GC, Chief Risk/Comp Officer
|
SaleCommon Stock | 2,703 | $77.41 | $209,248.42 |
DisclosureSEC source: 0001225208-20-008222 · doc4.xml · nonDerivative · entry 1 Hartman Todd G. · CIK 0001773763 · GC, Chief Risk/Comp Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,216.9498 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:38 UTC |
Furman Matthew MChief Comm & Publ. Affairs Ofc
|
SaleCommon Stock | 8,010 | $77.49 | $620,709.32 |
DisclosureSEC source: 0001225208-20-008221 · doc4.xml · nonDerivative · entry 1 Furman Matthew M · CIK 0001797085 · Chief Comm & Publ. Affairs Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,261 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:37 UTC |
Bilunas Matthew MChief Financial Officer
|
SaleCommon Stock | 1,752 | $77.41 | $135,628.28 |
DisclosureSEC source: 0001225208-20-008220 · doc4.xml · nonDerivative · entry 1 Bilunas Matthew M · CIK 0001784055 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,521 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:37 UTC |
Barry Corie SDirector · CEO
|
SaleCommon Stock | 18,844 | $77.49 | $1,460,255.48 |
DisclosureSEC source: 0001225208-20-008219 · doc4.xml · nonDerivative · entry 1 Barry Corie S · CIK 0001676999 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,323.65 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 22, 2020 Filed May 26, 2020 22:37 UTC |
Alexander Whitney LChief Transformation Officer
|
SaleCommon Stock | 3,128 | $77.41 | $242,149.12 |
DisclosureSEC source: 0001225208-20-008218 · doc4.xml · nonDerivative · entry 1 Alexander Whitney L · CIK 0001797374 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,379 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:24 UTC |
Watson MathewSVP, Finance-Controller & CAO
|
GrantCommon Stock | 3,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008185 · doc4.xml · nonDerivative · entry 1 Watson Mathew · CIK 0001639859 · SVP, Finance-Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,530 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Scarlett KathleenChief Human Resources Officer
|
GrantCommon Stock | 5,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008184 · doc4.xml · nonDerivative · entry 3 Scarlett Kathleen · CIK 0001707469 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,705 F3 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Scarlett KathleenChief Human Resources Officer
|
GrantCommon Stock | 6,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008184 · doc4.xml · nonDerivative · entry 2 Scarlett Kathleen · CIK 0001707469 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,491 F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on June 1, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Scarlett KathleenChief Human Resources Officer
|
GrantCommon Stock | 6,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008184 · doc4.xml · nonDerivative · entry 1 Scarlett Kathleen · CIK 0001707469 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,203 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Peterson AllisonChief Customer Officer
|
GrantCommon Stock | 3,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008183 · doc4.xml · nonDerivative · entry 1 Peterson Allison · CIK 0001811659 · Chief Customer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,601 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
MOHAN RAJENDRA MPresident & COO
|
GrantCommon Stock | 27,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008182 · doc4.xml · nonDerivative · entry 2 MOHAN RAJENDRA M · CIK 0001253507 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,676.293 F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
MOHAN RAJENDRA MPresident & COO
|
GrantCommon Stock | 27,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008182 · doc4.xml · nonDerivative · entry 1 MOHAN RAJENDRA M · CIK 0001253507 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,529.293 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Joly HubertDirector
|
GrantCommon Stock | 97,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008181 · doc4.xml · nonDerivative · entry 2 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,704.261 F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Joly HubertDirector
|
GrantCommon Stock | 98,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008181 · doc4.xml · nonDerivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,427.261 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Hartman Todd G.GC, Chief Risk/Comp Officer
|
GrantCommon Stock | 5,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008180 · doc4.xml · nonDerivative · entry 1 Hartman Todd G. · CIK 0001773763 · GC, Chief Risk/Comp Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,919.9498 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Furman Matthew MChief Comm & Publ. Affairs Ofc
|
GrantCommon Stock | 7,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008179 · doc4.xml · nonDerivative · entry 2 Furman Matthew M · CIK 0001797085 · Chief Comm & Publ. Affairs Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,271 F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Furman Matthew MChief Comm & Publ. Affairs Ofc
|
GrantCommon Stock | 7,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008179 · doc4.xml · nonDerivative · entry 1 Furman Matthew M · CIK 0001797085 · Chief Comm & Publ. Affairs Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,579 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Barry Corie SDirector · CEO
|
GrantCommon Stock | 18,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008178 · doc4.xml · nonDerivative · entry 2 Barry Corie S · CIK 0001676999 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,167.65 F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Barry Corie SDirector · CEO
|
GrantCommon Stock | 18,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008178 · doc4.xml · nonDerivative · entry 1 Barry Corie S · CIK 0001676999 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,068.65 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Bilunas Matthew MChief Financial Officer
|
GrantCommon Stock | 3,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008177 · doc4.xml · nonDerivative · entry 1 Bilunas Matthew M · CIK 0001784055 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,273 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Alexander Whitney LChief Transformation Officer
|
GrantCommon Stock | 6,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008176 · doc4.xml · nonDerivative · entry 1 Alexander Whitney L · CIK 0001797374 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,507 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Saksena AsheeshPresident, Best Buy Health
|
GrantCommon Stock | 9,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 4 Saksena Asheesh · CIK 0001701497 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,896.583 F4 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on April 28, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Saksena AsheeshPresident, Best Buy Health
|
GrantCommon Stock | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 3 Saksena Asheesh · CIK 0001701497 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,104.583 F3 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on April 28, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Saksena AsheeshPresident, Best Buy Health
|
GrantCommon Stock | 11,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 2 Saksena Asheesh · CIK 0001701497 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,204.583 F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:23 UTC |
Saksena AsheeshPresident, Best Buy Health
|
GrantCommon Stock | 11,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 1 Saksena Asheesh · CIK 0001701497 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,892.583 F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020. Read SEC document |
| May 08, 2020 Filed May 11, 2020 21:05 UTC |
Tilzer Brian AChief Digital & Tech Officer
|
SaleCommon Stock | 3,137 | $77.03 | $241,633.70 |
DisclosureSEC source: 0001225208-20-007413 · doc4.xml · nonDerivative · entry 1 Tilzer Brian A · CIK 0001697130 · Chief Digital & Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,912 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| April 21, 2020 Filed Apr 30, 2020 20:52 UTC |
Hartman Todd G.GC, Chief Risk/Comp Officer
|
SaleCommon Stock | 1,179 | $67.97 | $80,134.27 |
DisclosureSEC source: 0001225208-20-006922 · doc4.xml · nonDerivative · entry 1 Hartman Todd G. · CIK 0001773763 · GC, Chief Risk/Comp Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,705.9498 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 21:17 UTC |
Tilzer Brian AChief Digital & Tech Officer
|
SaleCommon Stock | 8 | $67.08 | $536.63 |
DisclosureSEC source: 0001225208-20-006580 · doc4.xml · nonDerivative · entry 1 Tilzer Brian A · CIK 0001697130 · Chief Digital & Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,049 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the settlement of restricted shares earned as dividend equivalents and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 21:17 UTC |
Watson MathewSVP, Finance-Controller & CAO
|
SaleCommon Stock | 7 | $67.08 | $469.55 |
DisclosureSEC source: 0001225208-20-006581 · doc4.xml · nonDerivative · entry 1 Watson Mathew · CIK 0001639859 · SVP, Finance-Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,150 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the settlement of restricted shares earned as dividend equivalents and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 21:17 UTC |
Scarlett KathleenChief Human Resources Officer
|
SaleCommon Stock | 8 | $67.08 | $536.63 |
DisclosureSEC source: 0001225208-20-006579 · doc4.xml · nonDerivative · entry 1 Scarlett Kathleen · CIK 0001707469 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,846 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the settlement of restricted shares earned as dividend equivalents and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.